# Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults

> **NCT02126462** · PHASE1 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 32 (actual)

## Conditions studied

- Hookworm Infection
- Hookworm Disease

## Interventions

- **BIOLOGICAL:** Na-APR-1 (M74)/Alhydrogel®
- **BIOLOGICAL:** Na-GST-1/Alhydrogel®
- **BIOLOGICAL:** Hepatitis B vaccine

## Key facts

- **NCT ID:** NCT02126462
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-02
- **Final completion:** 2016-06
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02126462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02126462, "Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02126462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*